drugset / Trial / NCT00162279

The Study of Abatacept in Combination With Etanercept

NCT00162279

Phase 2 Completed 141 enrolled Bristol-Myers Squibb
RandomizedSingle-groupDouble-blindTreatment

Summary

The Study was designed to look at the safety and efficacy of abatacept in combination with etanercept.

Timeline

Start
2000-10
Primary completion
2007-02
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Abatacept Other / unclassified 10 mg/kg Intravenous

Indications